Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review

Type 2 inflammation in cystic fibrosis: New insights

(2022) Sara Manti et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Real-world effectiveness of omalizumab in severe allergic asthma: a meta-analysis of observational studies

(2021) Jean Bousquet et al.   Journal of Allergy and Clinical Immunology-In Practice

Fungal Infection and Inflammation in Cystic Fibrosis

(2021) T. Spencer Poore et al.   Pathogens

Allergic Diseases Caused by Aspergillus Species in Patients with Cystic Fibrosis

(2021) Aidan K. Curran et al.   Antibiotics-Basel

Successful Treatment of Mepolizumab- and Prednisolone-resistant Allergic Bronchopulmonary Aspergillosis with Dupilumab

(2021) Sunao Mikura et al.   INTERNAL MEDICINE

Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: A case report

(2021) Tadashi Nishimura et al.   World Journal of Clinical Cases

Use of mepolizumab in adult patients with cystic fibrosis and an eosinophilic phenotype: case series

(2020) Lijia Zhang et al.   Allergy Asthma and Clinical Immunology

Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps

(2020) Harsha H Kariyawasam et al.   Drug Design Development and Therapy

EAACI Biologicals Guidelines—Recommendations for severe asthma

(2020) Ioana Agache et al.   ALLERGY

Efficacy and safety of omalizumab in children with moderate-to-severe asthma: a meta-analysis

(2020) Zhuo Fu et al.   JOURNAL OF ASTHMA

CFTR Modulators Dampen Aspergillus-Induced Reactive Oxygen Species Production by Cystic Fibrosis Phagocytes

(2020) Alexander J. Currie et al.   Frontiers in Cellular and Infection Microbiology

Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?

(2020) Carlo Mümmler et al.   Allergy Asthma and Clinical Immunology

High-Frequency Direct Detection of Triazole Resistance in Aspergillus fumigatus from Patients with Chronic Pulmonary Fungal Diseases in India

(2020) Ashutosh Singh et al.   Journal of Fungi

Current Approach in the Diagnosis and Management of Allergic Bronchopulmonary Aspergillosis in Children With Cystic Fibrosis

(2020) Birce Sunman et al.   Frontiers in Pediatrics

Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review

(2019) Giuseppe Fabio Parisi et al.   Journal of Allergy and Clinical Immunology-In Practice

Omalizumab for asthma and allergic bronchopulmonary aspergillosis in adults with cystic fibrosis

(2019) Angela Koutsokera et al.   Journal of Cystic Fibrosis

Prevention of drug-related complications in cystic fibrosis

(2019) Renske van der Meer et al.   CURRENT OPINION IN PULMONARY MEDICINE

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

(2019) Peter G. Middleton et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dupilumab treatment for allergic bronchopulmonary aspergillosis: A case series

(2019) Richard Paul Ramonell et al.   Journal of Allergy and Clinical Immunology-In Practice

Uses of biologics in allergic diseases

(2018) Tara Vinyette Saco et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

The spectrum of pulmonary aspergillosis

(2018) Amjad Kanj et al.   RESPIRATORY MEDICINE

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma

(2018) Sumita Khatri et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience

(2017) Bradley E. Chipps et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis

(2017) Caroline Perisson et al.   RESPIRATORY MEDICINE

Treating allergic bronchopulmonary aspergillosis: the way forward

(2016) Richard B. Moss   EUROPEAN RESPIRATORY JOURNAL

Cystic fibrosis

(2016) J Stuart Elborn   LANCET

Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients

(2016) Raphaële Nové-Josserand et al.   PEDIATRIC PULMONOLOGY

Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis

(2016) Ritesh Agarwal et al.   Expert Review of Respiratory Medicine

Omalizumab Treatment for Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis

(2015) Nagehan Emiralioglu et al.   ANNALS OF PHARMACOTHERAPY

Prevalence ofAspergillussensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis

(2015) V. N. Maturu et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Papel de omalizumab en el tratamiento de la aspergilosis broncopulmonar alérgica en pacientes con fibrosis quística

(2015) Isabel Delgado Pecellín et al.   MEDICINA CLINICA

Precision Medicine — Personalized, Problematic, and Promising

(2015) J. Larry Jameson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fungi in the cystic fibrosis lung: Bystanders or pathogens?

(2014) Sanjay H. Chotirmall et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

(2014) Sylvia Lehmann et al.   Therapeutic Advances in Respiratory Disease

Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria

(2013) R. Agarwal et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Novel immunologic classification of aspergillosis in adult cystic fibrosis

(2013) Caroline G. Baxter et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

What is the clinical significance of filamentous fungi positive sputum cultures in patients with cystic fibrosis?

(2013) Jane C. Liu et al.   Journal of Cystic Fibrosis

Omalizumab in the management of steroid dependent Allergic Bronchopulmonary Aspergillosis (ABPA) complicating Cystic Fibrosis

(2013) Rachel Wong et al.   Paediatric Respiratory Reviews

Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: A synthesis of published evidence

(2013) Kalliopi Tanou et al.   PEDIATRIC PULMONOLOGY

Allergic Bronchopulmonary Aspergillosis and Related Allergic Syndromes

(2011) Celia Hogan et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Lack of Cystic Fibrosis Transmembrane Conductance Regulator in CD3+Lymphocytes Leads to Aberrant Cytokine Secretion and Hyperinflammatory Adaptive Immune Responses

(2010) Christian Mueller et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis

(2010) Christopher R. Sudfeld et al.   Journal of Cystic Fibrosis

Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis

(2009) F. Brinkmann et al.   ALLERGY

Safety and tolerability of omalizumab

(2009) J. Corren et al.   CLINICAL AND EXPERIMENTAL ALLERGY

IL-5- and eosinophil-mediated inflammation: from discovery to therapy

(2009) T. Kouro et al.   INTERNATIONAL IMMUNOLOGY

Resolution of Corticosteroid-Induced Diabetes in Allergic Bronchopulmonary Aspergillosis with Omalizumab Therapy: A Novel Approach

(2009) Inderpal Randhawa et al.   JOURNAL OF ASTHMA

Competing interest bias in academic publications

(2009) Jocalyn Clark   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE

Omalizumab for treatment of ABPA exacerbations in CF patients

(2009) Patrick Lebecque et al.   PEDIATRIC PULMONOLOGY

Randomized Controlled Trial of Oral Antifungal Treatment for Severe Asthma with Fungal Sensitization

(2008) David W. Denning et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis

(2008) Jacquelyn M. Zirbes et al.   PEDIATRIC PULMONOLOGY

Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab)

(2008) Adaobi Kanu et al.   PEDIATRIC PULMONOLOGY